1.Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
2.Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China
3.Global Statistics and Data Science, BeiGene, Shanghai 200001, China
4.School of Statistics, Renmin University of China, Beijing 100872, China
5.School of Public Health, Qingdao University, Qingdao 266071, Shandong, China
6.Minzu University of China, Beijing 100081, China
7.Department of Clinical Research Management, the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China
Author bio:
* Ning Li ncctrials@cicams.ac.cn
Funds:
the National Natural Science Foundation of China(82303955);the Beijing Nova Program(20230484277)
Hui-Yao Huang, Le Wang, Sheng Xu, 等. Target trial emulation in oncology: current use and future directions[J/OL]. Military Medical Research, 2025,12.
Hui-Yao Huang, Le Wang, Sheng Xu, et al. Target trial emulation in oncology: current use and future directions[J/OL]. Military Medical Research, 2025, 12.
Hui-Yao Huang, Le Wang, Sheng Xu, 等. Target trial emulation in oncology: current use and future directions[J/OL]. Military Medical Research, 2025,12. DOI: 10.1186/s40779-026-00685-9.
Hui-Yao Huang, Le Wang, Sheng Xu, et al. Target trial emulation in oncology: current use and future directions[J/OL]. Military Medical Research, 2025, 12. DOI: 10.1186/s40779-026-00685-9.
Target trial emulation in oncology: current use and future directions